Honeywell et al. illustrated in their research how miR-105 obtained from tumor-derived extracellular vesicles serves as a tumor suppressor and targets the cyclin-dependent kinase 6 (CDK6), which suppresses the cell proliferation[110]. The gene discussed is CDK6; the disease is neoplasm.